| Year |
Citation |
Score |
| 2024 |
Nayak SM, White SH, Hilbert SN, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study. Journal of Psychoactive Drugs. 1-10. PMID 38715376 DOI: 10.1080/02791072.2024.2346130 |
0.756 |
|
| 2024 |
Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK. The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. Plos One. 19: e0300501. PMID 38483940 DOI: 10.1371/journal.pone.0300501 |
0.73 |
|
| 2023 |
Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A. Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers. Psychedelic Medicine (New Rochelle, N.Y.). 1: 241-252. PMID 38152462 DOI: 10.1089/psymed.2023.0035 |
0.755 |
|
| 2023 |
Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory. Psychological Review. PMID 38095937 DOI: 10.1037/rev0000455 |
0.782 |
|
| 2023 |
Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, et al. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Frontiers in Psychiatry. 14: 1199642. PMID 37795509 DOI: 10.3389/fpsyt.2023.1199642 |
0.767 |
|
| 2023 |
Urrutia J, Anderson BT, Belouin SJ, Berger A, Griffiths RR, Grob CS, Henningfield JE, Labate BC, Maier LJ, Maternowska MC, Weichold F, Yaden DB, Magar V. Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. Journal of Psychoactive Drugs. 1-16. PMID 37747281 DOI: 10.1080/02791072.2023.2258367 |
0.549 |
|
| 2023 |
Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434. Neuroimage. 274: 120130. PMID 37148779 DOI: 10.1016/j.neuroimage.2023.120130 |
0.703 |
|
| 2022 |
Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF. Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. Frontiers in Neuroergonomics. 2: 784576. PMID 38235248 DOI: 10.3389/fnrgo.2021.784576 |
0.77 |
|
| 2022 |
Nikolaidis A, Lancelotta R, Gukasyan N, Griffiths RR, Barrett FS, Davis AK. Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms. Journal of Affective Disorders. 324: 239-249. PMID 36584715 DOI: 10.1016/j.jad.2022.12.042 |
0.737 |
|
| 2022 |
Kiluk BD, Kleykamp BA, Comer SD, Griffiths RR, Huhn AS, Johnson MW, Kampman KM, Pravetoni M, Preston KL, Vandrey R, Bergeria CL, Bogenschutz MP, Brown RT, Dunn KE, Dworkin RH, et al. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. Jama Psychiatry. PMID 36449315 DOI: 10.1001/jamapsychiatry.2022.4020 |
0.779 |
|
| 2022 |
Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. Plos One. 17: e0271926. PMID 36001643 DOI: 10.1371/journal.pone.0271926 |
0.71 |
|
| 2022 |
Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology. 109220. PMID 35987353 DOI: 10.1016/j.neuropharm.2022.109220 |
0.62 |
|
| 2022 |
Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. PSILOCYBIN INDUCES SPATIALLY CONSTRAINED ALTERATIONS IN THALAMIC FUNCTIONAL ORGANIZATON AND CONNECTIVITY. Neuroimage. 119434. PMID 35792293 DOI: 10.1016/j.neuroimage.2022.119434 |
0.729 |
|
| 2022 |
Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology (Oxford, England). 36: 151-158. PMID 35166158 DOI: 10.1177/02698811211073759 |
0.755 |
|
| 2021 |
Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS. Models of psychedelic drug action: modulation of cortical-subcortical circuits. Brain : a Journal of Neurology. PMID 34897383 DOI: 10.1093/brain/awab406 |
0.779 |
|
| 2021 |
Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Translational Psychiatry. 11: 574. PMID 34750350 DOI: 10.1038/s41398-021-01706-y |
0.771 |
|
| 2021 |
Bobe JR, Jutras BL, Horn EJ, Embers ME, Bailey A, Moritz RL, Zhang Y, Soloski MJ, Ostfeld RS, Marconi RT, Aucott J, Ma'ayan A, Keesing F, Lewis K, Ben Mamoun C, ... ... Griffiths RR, et al. Recent Progress in Lyme Disease and Remaining Challenges. Frontiers in Medicine. 8: 666554. PMID 34485323 DOI: 10.3389/fmed.2021.666554 |
0.735 |
|
| 2021 |
Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. PMID 34348413 DOI: 10.1055/a-1524-2794 |
0.724 |
|
| 2021 |
Yaden DB, Johnson MW, Griffiths RR, Doss M, Garcia-Romeu A, Nayak S, Gukasayan N, Mathur BN, Barrett FS. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities. The International Journal of Neuropsychopharmacology. PMID 33987652 DOI: 10.1093/ijnp/pyab026 |
0.769 |
|
| 2021 |
Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of Psychopharmacology (Oxford, England). 269881121991822. PMID 33611977 DOI: 10.1177/0269881121991822 |
0.786 |
|
| 2021 |
Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology (Oxford, England). 269881120967878. PMID 33427007 DOI: 10.1177/0269881120967878 |
0.735 |
|
| 2020 |
Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 33146667 DOI: 10.1001/jamapsychiatry.2020.3285 |
0.76 |
|
| 2020 |
Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, Griffiths RR, Barrett FS. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain. Scientific Reports. 10: 16392. PMID 33009457 DOI: 10.1038/s41598-020-73216-8 |
0.769 |
|
| 2020 |
Davis AK, Barrett FS, Griffiths RR. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science. 15: 39-45. PMID 32864325 DOI: 10.1016/J.Jcbs.2019.11.004 |
0.746 |
|
| 2020 |
Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology. PMID 32500212 DOI: 10.1007/s00213-020-05533-9 |
0.777 |
|
| 2020 |
Barrett FS, Krimmel SR, Griffiths R, Seminowicz DA, Mathur BN. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. Neuroimage. 116980. PMID 32454209 DOI: 10.1016/J.Neuroimage.2020.116980 |
0.741 |
|
| 2020 |
Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR. Survey of entity encounter experiences occasioned by inhaled -dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology (Oxford, England). 269881120916143. PMID 32345112 DOI: 10.1177/0269881120916143 |
0.426 |
|
| 2020 |
Sweeney MM, Weaver DC, Vincent KB, Arria AM, Griffiths RR. Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample. Journal of Caffeine and Adenosine Research. 10: 4-11. PMID 32181442 DOI: 10.1089/caff.2019.0020 |
0.695 |
|
| 2020 |
Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports. 10: 2214. PMID 32042038 DOI: 10.1038/S41598-020-59282-Y |
0.782 |
|
| 2020 |
Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence. 107849. PMID 32029298 DOI: 10.1016/J.Drugalcdep.2020.107849 |
0.778 |
|
| 2019 |
Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Frontiers in Psychiatry. 10: 955. PMID 32038317 DOI: 10.3389/Fpsyt.2019.00955 |
0.776 |
|
| 2019 |
Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881119845793. PMID 31084460 DOI: 10.1177/0269881119845793 |
0.779 |
|
| 2019 |
Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Plos One. 14: e0214377. PMID 31013281 DOI: 10.1371/journal.pone.0214377 |
0.461 |
|
| 2018 |
Sweeney MM, Meredith SE, Juliano LM, Evatt DP, Griffiths RR. A randomized controlled trial of a manual-only treatment for reduction and cessation of problematic caffeine use. Drug and Alcohol Dependence. 195: 45-51. PMID 30580203 DOI: 10.1016/J.Drugalcdep.2018.10.034 |
0.778 |
|
| 2018 |
Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics. Pharmacology & Therapeutics. PMID 30521880 DOI: 10.1016/J.Pharmthera.2018.11.010 |
0.784 |
|
| 2018 |
Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology. PMID 30062577 DOI: 10.1007/S00213-018-4981-X |
0.805 |
|
| 2018 |
Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology (Oxford, England). 269881118780612. PMID 29938565 DOI: 10.1177/0269881118780612 |
0.776 |
|
| 2018 |
Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology. PMID 29753748 DOI: 10.1016/J.Neuropharm.2018.05.012 |
0.685 |
|
| 2018 |
McKenna M, Fedota J, Garcia-Romeu A, Johnson M, Griffiths R, Stein E. T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers Biological Psychiatry. 83: S231-S232. DOI: 10.1016/J.Biopsych.2018.02.600 |
0.754 |
|
| 2017 |
Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology. PMID 29116367 DOI: 10.1007/s00213-017-4769-4 |
0.769 |
|
| 2017 |
Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England). 269881117731279. PMID 29020861 DOI: 10.1177/0269881117731279 |
0.803 |
|
| 2017 |
Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions. Frontiers in Psychology. 8: 1238. PMID 28790944 DOI: 10.3389/Fpsyg.2017.01238 |
0.754 |
|
| 2017 |
Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 117: 155-160. PMID 28781400 DOI: 10.1016/J.Paid.2017.06.004 |
0.77 |
|
| 2017 |
Johnson MW, Griffiths RR. Potential Therapeutic Effects of Psilocybin. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28585222 DOI: 10.1007/s13311-017-0542-y |
0.478 |
|
| 2017 |
Barrett FS, Griffiths RR. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences. PMID 28401522 DOI: 10.1007/7854_2017_474 |
0.764 |
|
| 2017 |
Barrett FS, Griffiths RR. The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016. Human Psychopharmacology. 32. PMID 28120488 DOI: 10.1002/Hup.2564 |
0.704 |
|
| 2017 |
Sweeney MM, Meredith SE, Evatt DP, Griffiths RR. Effects of caffeine on alcohol reinforcement: beverage choice, self-administration, and subjective ratings. Psychopharmacology. PMID 28108773 DOI: 10.1007/S00213-017-4528-6 |
0.773 |
|
| 2017 |
Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881116684335. PMID 28095732 DOI: 10.1177/0269881116684335 |
0.778 |
|
| 2017 |
Garcia-Romeu A, Griffiths RR, Johnson MW. Psychedelic-associated addiction remission: An online survey Drug and Alcohol Dependence. 171: e69. DOI: 10.1016/J.Drugalcdep.2016.08.199 |
0.74 |
|
| 2017 |
Carbonaro TM, Johnson MW, Griffiths RR. Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings Drug and Alcohol Dependence. 171: e34. DOI: 10.1016/j.drugalcdep.2016.08.107 |
0.752 |
|
| 2017 |
Barrett FS, Johnson MW, Griffiths RR. Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience Drug and Alcohol Dependence. 171: e15-e16. DOI: 10.1016/J.Drugalcdep.2016.08.058 |
0.754 |
|
| 2016 |
Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England). 30: 1181-1197. PMID 27909165 DOI: 10.1177/0269881116675513 |
0.457 |
|
| 2016 |
Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England). PMID 27856683 DOI: 10.1177/0269881116678781 |
0.776 |
|
| 2016 |
Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England). PMID 27578767 DOI: 10.1177/0269881116662634 |
0.788 |
|
| 2016 |
Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse. 1-6. PMID 27441452 DOI: 10.3109/00952990.2016.1170135 |
0.787 |
|
| 2016 |
Meredith SE, Sweeney MM, Johnson PS, Johnson MW, Griffiths RR. Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults. Journal of Caffeine Research. 6: 10-19. PMID 26989563 DOI: 10.1089/Jcr.2015.0024 |
0.775 |
|
| 2016 |
Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans. Journal of Psychopharmacology (Oxford, England). PMID 26880225 DOI: 10.1177/0269881116629125 |
0.762 |
|
| 2016 |
Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, et al. Naltrexone but not ketanserin antagonizes the subjective, cardiovascular and neuroendocrine effects of salvinorin-A in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26874330 DOI: 10.1093/Ijnp/Pyw016 |
0.407 |
|
| 2015 |
Evatt DP, Juliano LM, Griffiths RR. A Brief Manualized Treatment for Problematic Caffeine Use: A Randomized Control Trial. Journal of Consulting and Clinical Psychology. PMID 26501499 DOI: 10.1037/Ccp0000064 |
0.668 |
|
| 2015 |
Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England). 29: 1182-90. PMID 26442957 DOI: 10.1177/0269881115609019 |
0.792 |
|
| 2015 |
Hendricks PS, Johnson MW, Griffiths RR. Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacology (Oxford, England). 29: 1041-3. PMID 26395582 DOI: 10.1177/0269881115598338 |
0.408 |
|
| 2015 |
Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacology. PMID 26345343 DOI: 10.1007/S00213-015-4053-4 |
0.731 |
|
| 2015 |
Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J. Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26047623 DOI: 10.1093/Ijnp/Pyv065 |
0.442 |
|
| 2015 |
Reissig CJ, Harrison JA, Carter LP, Griffiths RR. Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potential. Psychopharmacology. 232: 871-83. PMID 25199955 DOI: 10.1007/S00213-014-3721-0 |
0.805 |
|
| 2015 |
Garcia-Romeu AP, Noorani T, Griffiths RR, Johnson MW. Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts Drug and Alcohol Dependence. 156: e78. DOI: 10.1016/J.Drugalcdep.2015.07.1130 |
0.742 |
|
| 2015 |
Carbonaro TM, Klinedinst M, Johnson MW, Griffiths RR. Comparative phenomenology of psilocybin experiences in research and non-research settings Drug and Alcohol Dependence. 156: e36-e37. DOI: 10.1016/j.drugalcdep.2015.07.1017 |
0.715 |
|
| 2015 |
Meredith SE, Evatt D, Strain EC, Griffiths RR. Caffeine increases the reinforcing effects of alcohol in some social drinkers Drug and Alcohol Dependence. 146: e38-e39. DOI: 10.1016/J.Drugalcdep.2014.09.476 |
0.603 |
|
| 2015 |
Garcia-Romeu AP, Griffiths RR, Johnson MW. Psychedelic-facilitated smoking cessation: An online survey Drug and Alcohol Dependence. 146: e120. DOI: 10.1016/J.Drugalcdep.2014.09.245 |
0.735 |
|
| 2015 |
Carbonaro TM, Barrett FS, Bradstreet MP, Johnson MW, MacLean KA, Jesse R, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology Drug and Alcohol Dependence. 146: e239-e240. DOI: 10.1016/J.Drugalcdep.2014.09.118 |
0.771 |
|
| 2015 |
Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, MacLean KA, Jesse R, Griffiths RR. The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin Drug and Alcohol Dependence. 146: e218. DOI: 10.1016/J.Drugalcdep.2014.09.060 |
0.768 |
|
| 2014 |
Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews. 7: 157-64. PMID 25563443 DOI: 10.2174/1874473708666150107121331 |
0.8 |
|
| 2014 |
Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England). 28: 983-92. PMID 25213996 DOI: 10.1177/0269881114548296 |
0.789 |
|
| 2014 |
Garcia-Romeu AP, Johnson MW, Griffiths RR. Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study Drug and Alcohol Dependence. 140: e66. DOI: 10.1016/J.Drugalcdep.2014.02.200 |
0.787 |
|
| 2014 |
Bradstreet MP, Johnson MW, MacLean KA, Griffiths RR. Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin Drug and Alcohol Dependence. 140: e18-e19. DOI: 10.1016/J.Drugalcdep.2014.02.072 |
0.658 |
|
| 2013 |
Meredith SE, Juliano LM, Hughes JR, Griffiths RR. Caffeine Use Disorder: A Comprehensive Review and Research Agenda. Journal of Caffeine Research. 3: 114-130. PMID 24761279 DOI: 10.1089/Jcr.2013.0016 |
0.786 |
|
| 2013 |
Budney AJ, Brown PC, Griffiths RR, Hughes JR, Juliano LM. Caffeine Withdrawal and Dependence: A Convenience Survey Among Addiction Professionals. Journal of Caffeine Research. 3: 67-71. PMID 24761276 DOI: 10.1089/Jcr.2013.0005 |
0.668 |
|
| 2013 |
Caspers MJ, Williams TD, Lovell KM, Lozama A, Butelman ER, Kreek MJ, Johnson M, Griffiths R, Maclean K, Prisinzano TE. LC-MS/MS quantification of salvinorin A from biological fluids. Analytical Methods : Advancing Methods and Applications. 5. PMID 24416081 DOI: 10.1039/C3Ay40810H |
0.707 |
|
| 2013 |
Johnson MW, Griffiths RR. Comparative abuse liability of GHB and ethanol in humans. Experimental and Clinical Psychopharmacology. 21: 112-23. PMID 23421353 DOI: 10.1037/a0031692 |
0.507 |
|
| 2013 |
MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology. 226: 381-92. PMID 23135605 DOI: 10.1007/S00213-012-2912-9 |
0.826 |
|
| 2013 |
Carter LP, Kleykamp BA, Griffiths RR, Mintzer MZ. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers. Psychopharmacology. 226: 53-63. PMID 23096769 DOI: 10.1007/S00213-012-2883-X |
0.801 |
|
| 2013 |
Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug and Alcohol Dependence. 128: 206-13. PMID 22989498 DOI: 10.1016/J.Drugalcdep.2012.08.025 |
0.807 |
|
| 2013 |
Striley MCW, Hughes PJR, Griffiths R, Juliano L, Budney AJ. A Critical Examination of the Caffeine Provisions in the Diagnostic and Statistical Manual, 5th Edition (DSM-5) Journal of Caffeine Research. 3: 101-107. DOI: 10.1089/Jcr.2013.1233 |
0.654 |
|
| 2013 |
Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Corrigendum to Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans [Drug Alcohol Depend. 128 (2013) 206-213] Drug and Alcohol Dependence. 133: 294. DOI: 10.1016/J.Drugalcdep.2013.06.006 |
0.78 |
|
| 2013 |
Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens Psychopharmacology. 228: 513-513. DOI: 10.1007/S00213-013-3172-Z |
0.795 |
|
| 2012 |
Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal For the Scientific Study of Religion. 51: 721-737. PMID 23316089 DOI: 10.1111/J.1468-5906.2012.01685.X |
0.723 |
|
| 2012 |
Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 223: 1-15. PMID 22526529 DOI: 10.1007/S00213-012-2680-6 |
0.818 |
|
| 2012 |
Juliano LM, Evatt DP, Richards BD, Griffiths RR. Characterization of individuals seeking treatment for caffeine dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 26: 948-54. PMID 22369218 DOI: 10.1037/A0027246 |
0.689 |
|
| 2012 |
Johnson MW, Sewell RA, Griffiths RR. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug and Alcohol Dependence. 123: 132-40. PMID 22129843 DOI: 10.1016/j.drugalcdep.2011.10.029 |
0.498 |
|
| 2012 |
Kleykamp BA, Griffiths RR, McCann UD, Smith MT, Mintzer MZ. Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use. Experimental and Clinical Psychopharmacology. 20: 28-39. PMID 21928913 DOI: 10.1037/A0025237 |
0.791 |
|
| 2011 |
MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology (Oxford, England). 25: 1453-61. PMID 21956378 DOI: 10.1177/0269881111420188 |
0.735 |
|
| 2011 |
Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 218: 649-65. PMID 21674151 DOI: 10.1007/s00213-011-2358-5 |
0.525 |
|
| 2011 |
Sigmon SC, Griffiths RR. Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine. Drug and Alcohol Dependence. 118: 341-8. PMID 21600707 DOI: 10.1016/J.Drugalcdep.2011.04.018 |
0.705 |
|
| 2011 |
Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence. 115: 150-5. PMID 21131142 DOI: 10.1016/J.Drugalcdep.2010.11.005 |
0.819 |
|
| 2011 |
Goodwin AK, Kaminski BJ, Griffiths RR, Ator NA, Weerts EM. Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons. Drug and Alcohol Dependence. 114: 217-24. PMID 21112162 DOI: 10.1016/J.Drugalcdep.2010.10.006 |
0.597 |
|
| 2010 |
Jefferies D, Johnson M, Griffiths R, Arthurs K, Beard D, Chen T, Edgetton-Winn M, Hecimovic T, Hughes M, Linten K, Maddox J, McCaul D, Robson K, Scott S, Zarkos T. Engaging clinicians in evidence based policy development: the case of nursing documentation. Contemporary Nurse. 35: 254-64. PMID 20950205 DOI: 10.5172/conu.2010.35.2.254 |
0.358 |
|
| 2010 |
Johnson MW, Strain EC, Griffiths RR. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Experimental and Clinical Psychopharmacology. 18: 305-15. PMID 20695686 DOI: 10.1037/a0020509 |
0.467 |
|
| 2010 |
Jefferies D, Johnson M, Griffiths R. A meta-study of the essentials of quality nursing documentation. International Journal of Nursing Practice. 16: 112-24. PMID 20487056 DOI: 10.1111/j.1440-172X.2009.01815.x |
0.36 |
|
| 2010 |
Mintzer MZ, Kleykamp BA, Griffiths RR. Dose effects of triazolam and scopolamine on metamemory. Experimental and Clinical Psychopharmacology. 18: 17-31. PMID 20158291 DOI: 10.1037/A0018061 |
0.806 |
|
| 2010 |
Kleykamp BA, Griffiths RR, Mintzer MZ. Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Experimental and Clinical Psychopharmacology. 18: 1-16. PMID 20158290 DOI: 10.1037/A0018407 |
0.798 |
|
| 2009 |
Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Does implementation of clinical practice guidelines change nurses' screening for alcohol and other substance use? Contemporary Nurse. 33: 13-9. PMID 19715491 DOI: 10.5555/conu.33.1.13 |
0.407 |
|
| 2009 |
Carter LP, Griffiths RR, Mintzer MZ. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacology. 206: 141-54. PMID 19543883 DOI: 10.1007/S00213-009-1589-1 |
0.815 |
|
| 2009 |
Carter LP, Pardi D, Gorsline J, Griffiths RR. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug and Alcohol Dependence. 104: 1-10. PMID 19493637 DOI: 10.1016/J.Drugalcdep.2009.04.012 |
0.681 |
|
| 2009 |
Carter LP, Griffiths RR. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence. 105: S14-25. PMID 19443137 DOI: 10.1016/J.Drugalcdep.2009.04.003 |
0.698 |
|
| 2009 |
Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Changes in general nurses' knowledge of alcohol and substance use and misuse after education. Perspectives in Psychiatric Care. 45: 128-39. PMID 19366423 DOI: 10.1111/j.1744-6163.2009.00213.x |
0.37 |
|
| 2009 |
Sigmon SC, Herning RI, Better W, Cadet JL, Griffiths RR. Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology. 204: 573-85. PMID 19241060 DOI: 10.1007/S00213-009-1489-4 |
0.682 |
|
| 2009 |
Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks--a growing problem. Drug and Alcohol Dependence. 99: 1-10. PMID 18809264 DOI: 10.1016/J.Drugalcdep.2008.08.001 |
0.706 |
|
| 2009 |
Carter LP, Mintzer MZ, Griffiths RR. Amnestic effects of sodium oxybate are less than those of triazolam-reply to Drs. Zvosec and Smith Psychopharmacology. 207: 511-512. DOI: 10.1007/S00213-009-1664-7 |
0.79 |
|
| 2008 |
Griffiths R, Richards W, Johnson M, McCann U, Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England). 22: 621-32. PMID 18593735 DOI: 10.1177/0269881108094300 |
0.487 |
|
| 2008 |
Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology (Oxford, England). 22: 603-20. PMID 18593734 DOI: 10.1177/0269881108093587 |
0.44 |
|
| 2008 |
Griffiths RR, Reissig CJ, First MB. Substance Abuse: Caffeine Use Disorders Psychiatry: Third Edition. 1: 1019-1040. DOI: 10.1002/9780470515167.ch56 |
0.688 |
|
| 2007 |
Mintzer MZ, Griffiths RR. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. Cognitive, Affective & Behavioral Neuroscience. 7: 120-9. PMID 17672383 DOI: 10.3758/Cabn.7.2.120 |
0.758 |
|
| 2007 |
Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. The Journal of Pharmacology and Experimental Therapeutics. 322: 749-59. PMID 17502431 DOI: 10.1124/Jpet.107.119693 |
0.73 |
|
| 2007 |
Mintzer MZ, Griffiths RR. A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal. Psychopharmacology. 192: 425-40. PMID 17342474 DOI: 10.1007/S00213-007-0726-Y |
0.769 |
|
| 2007 |
Weerts EM, Froestl W, Kaminski BJ, Griffiths RR. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug and Alcohol Dependence. 89: 206-13. PMID 17234367 DOI: 10.1016/j.drugalcdep.2006.12.023 |
0.559 |
|
| 2006 |
Lofwall MR, Griffiths RR, Mintzer MZ. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults. Experimental and Clinical Psychopharmacology. 14: 439-49. PMID 17115871 DOI: 10.1037/1064-1297.14.4.439 |
0.77 |
|
| 2006 |
Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM, Weerts EM. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology. 189: 71-82. PMID 17047936 DOI: 10.1007/S00213-006-0534-9 |
0.595 |
|
| 2006 |
Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Archives of General Psychiatry. 63: 1149-57. PMID 17015817 DOI: 10.1001/archpsyc.63.10.1149 |
0.533 |
|
| 2006 |
Carter LP, Richards BD, Mintzer MZ, Griffiths RR. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2537-51. PMID 16880774 DOI: 10.1038/Sj.Npp.1301146 |
0.83 |
|
| 2006 |
Mintzer MZ, Kuwabara H, Alexander M, Brasic JR, Ye W, Ernst M, Griffiths RR, Wong DF. Dose effects of triazolam on brain activity during episodic memory encoding: a PET study. Psychopharmacology. 188: 445-61. PMID 16847681 DOI: 10.1007/S00213-006-0446-8 |
0.759 |
|
| 2006 |
Grudzinskas C, Balster RL, Gorodetzky CW, Griffiths RR, Henningfield JE, Johanson CE, Mansbach RS, McCormick CG, Schnoll SH, Strain EC, Wright C. Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report. Drug and Alcohol Dependence. 83: S77-82. PMID 16580154 DOI: 10.1016/J.Drugalcdep.2006.02.008 |
0.604 |
|
| 2005 |
Mintzer MZ, Griffiths RR. Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine. Experimental and Clinical Psychopharmacology. 13: 336-47. PMID 16366764 DOI: 10.1037/1064-1297.13.4.336 |
0.78 |
|
| 2005 |
Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. The Journal of Clinical Psychiatry. 66: 31-41. PMID 16336040 |
0.494 |
|
| 2005 |
Mintzer MZ, Griffiths RR. An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers. Behavioural Pharmacology. 16: 579-84. PMID 16170235 DOI: 10.1097/01.Fbp.0000172736.11994.3C |
0.784 |
|
| 2005 |
Weerts EM, Ator NA, Kaminski BJ, Griffiths RR. Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons. European Journal of Pharmacology. 519: 103-13. PMID 16129429 DOI: 10.1016/J.Ejphar.2005.06.038 |
0.607 |
|
| 2005 |
Weerts EM, Froestl W, Griffiths RR. Effects of GABAergic modulators on food and cocaine self-administration in baboons. Drug and Alcohol Dependence. 80: 369-76. PMID 16005580 DOI: 10.1016/j.drugalcdep.2005.05.006 |
0.565 |
|
| 2005 |
Ator NA, Griffiths RR, Weerts EM. Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons. Drug and Alcohol Dependence. 78: 113-23. PMID 15845314 DOI: 10.1016/J.Drugalcdep.2004.09.007 |
0.594 |
|
| 2005 |
Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nursing (Boston, Mass.). 22: 36-44. PMID 15670323 DOI: 10.1111/j.0737-1209.2005.22106.x |
0.374 |
|
| 2005 |
Weerts EM, Goodwin AK, Griffiths RR, Brown PR, Froestl W, Jakobs C, Gibson KM. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons. Psychopharmacology. 179: 678-87. PMID 15645222 DOI: 10.1007/S00213-004-2079-0 |
0.588 |
|
| 2005 |
Mintzer MZ, Griffiths RR. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure. Psychopharmacology. 178: 259-67. PMID 15452683 DOI: 10.1007/S00213-004-2009-1 |
0.768 |
|
| 2005 |
Goodwin A, Griffiths R, Froestl W, Gibson K, Burlingame T, Jansen E, Jakobs C, Weerts E. A92 ASSESSMENT OF GABAB ANTAGONIST PRECIPITATED WITHDRAWAL DURING CHRONIC ADMINISTRATION OF GAMMA-BUTYROLACTONE (GBL) Behavioural Pharmacology. 16: S52. DOI: 10.1097/00008877-200509001-00165 |
0.525 |
|
| 2004 |
Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features Psychopharmacology. 176: 1-29. PMID 15448977 DOI: 10.1007/S00213-004-2000-X |
0.664 |
|
| 2004 |
Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. International Journal of Nursing Practice. 10: 166-76. PMID 15265227 DOI: 10.1111/j.1440-172X.2004.00476.x |
0.37 |
|
| 2004 |
Sobel BFX, Sigmon SC, Griffiths RR. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers Neuropsychopharmacology. 29: 991-1003. PMID 15010695 DOI: 10.1038/Sj.Npp.1300415 |
0.699 |
|
| 2003 |
Kaminski BJ, Sannerud CA, Weerts EM, Lamb RJ, Griffiths RR. Physical dependence in baboons chronically treated with low and high doses of diazepam. Behavioural Pharmacology. 14: 331-42. PMID 12838039 DOI: 10.1097/01.Fbp.0000082131.08343.0E |
0.678 |
|
| 2003 |
Mintzer MZ, Griffiths RR, Hirshman E. A paradoxical dissociation in the effects of midazolam on recollection and automatic processes in the process dissociation procedure. The American Journal of Psychology. 116: 213-37. PMID 12762176 DOI: 10.2307/1423578 |
0.749 |
|
| 2003 |
Griffiths RR, Bigelow GE, Ator NA. Principles of initial experimental drug abuse liability assessment in humans. Drug and Alcohol Dependence. 70: S41-54. PMID 12759196 DOI: 10.1016/S0376-8716(03)00098-X |
0.55 |
|
| 2003 |
Mintzer MZ, Griffiths RR. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal. Journal of Psychopharmacology (Oxford, England). 17: 17-29. PMID 12680736 DOI: 10.1177/0269881103017001689 |
0.763 |
|
| 2003 |
Weerts EM, Griffiths RR. The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons. Psychopharmacology. 168: 155-63. PMID 12669180 DOI: 10.1007/s00213-003-1410-5 |
0.565 |
|
| 2003 |
Mintzer MZ, Griffiths RR. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes. Experimental and Clinical Psychopharmacology. 11: 56-72. PMID 12622344 DOI: 10.1037//1064-1297.11.1.56 |
0.776 |
|
| 2002 |
Mintzer MZ, Griffiths RR. Alcohol and triazolam: differential effects on memory, psychomotor performance and subjective ratings of effects. Behavioural Pharmacology. 13: 653-8. PMID 12478216 DOI: 10.1097/00008877-200212000-00007 |
0.765 |
|
| 2001 |
Johnson M, Griffiths R. Developing evidence-based clinicians. International Journal of Nursing Practice. 7: 109-18. PMID 11811313 |
0.378 |
|
| 2001 |
Mintzer MZ, Griffiths RR. Alcohol and false recognition: a dose-effect study. Psychopharmacology. 159: 51-7. PMID 11797069 DOI: 10.1007/S002130100893 |
0.759 |
|
| 2001 |
Mintzer MZ, Griffiths RR, Contoreggi C, Kimes AS, London ED, Ernst M. Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 744-56. PMID 11682258 DOI: 10.1016/S0893-133X(01)00280-9 |
0.753 |
|
| 2001 |
Mintzer MZ, Allen RP, Griffiths RR. Investigation of preference for nightly triazolam versus placebo in moderate social alcohol drinkers. Journal of Psychopharmacology (Oxford, England). 15: 3-8. PMID 11277606 DOI: 10.1177/026988110101500101 |
0.77 |
|
| 2001 |
Mintzer MZ, Griffiths RR. Acute dose-effects of scopolamine on false recognition. Psychopharmacology. 153: 425-33. PMID 11243489 DOI: 10.1007/S002130000592 |
0.782 |
|
| 2001 |
Mintzer MZ, Griffiths RR. False Recognition in Triazolam-Induced Amnesia Journal of Memory and Language. 44: 475-492. DOI: 10.1006/Jmla.2000.2746 |
0.773 |
|
| 2000 |
Mintzer MZ, Griffiths RR. Acute effects of triazolam on false recognition. Memory & Cognition. 28: 1357-65. PMID 11219963 DOI: 10.3758/Bf03211836 |
0.772 |
|
| 2000 |
Ator NA, Weerts EM, Kaminski BJ, Kautz MA, Griffiths RR. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug and Alcohol Dependence. 61: 69-84. PMID 11064185 DOI: 10.1016/S0376-8716(00)00122-8 |
0.606 |
|
| 1999 |
Weerts EM, Griffiths RR. Evaluation of limited and unlimited food intake during withdrawal in triazolam-dependent baboons. Behavioural Pharmacology. 10: 415-21. PMID 10780809 |
0.567 |
|
| 1999 |
Weerts EM, Ator NA, Griffiths RR. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug and Alcohol Dependence. 57: 51-60. PMID 10617313 DOI: 10.1016/S0376-8716(99)00044-7 |
0.592 |
|
| 1999 |
Mintzer MZ, Stoller KB, Griffiths RR. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 147: 200-9. PMID 10591888 DOI: 10.1007/S002130051161 |
0.774 |
|
| 1999 |
Rush CR, Frey JM, Griffiths RR. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacology. 145: 39-51. PMID 10445371 DOI: 10.1007/s002130051030 |
0.315 |
|
| 1999 |
Mintzer MZ, Griffiths RR. Triazolam and zolpidem: effects on human memory and attentional processes. Psychopharmacology. 144: 8-19. PMID 10379619 DOI: 10.1007/S002130050971 |
0.767 |
|
| 1999 |
Mintzer MZ, Griffiths RR. Selective effects of zolpidem on human memory functions. Journal of Psychopharmacology (Oxford, England). 13: 18-31. PMID 10221356 DOI: 10.1177/026988119901300103 |
0.756 |
|
| 1999 |
Weerts EM, Griffiths RR. Evaluation of the intravenous reinforcing effects of clonidine in baboons. Drug and Alcohol Dependence. 53: 207-14. PMID 10080046 DOI: 10.1016/S0376-8716(98)00130-6 |
0.591 |
|
| 1998 |
Mintzer MZ, Griffiths RR. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability. Drug and Alcohol Dependence. 53: 49-66. PMID 10933340 DOI: 10.1016/S0376-8716(98)00110-0 |
0.794 |
|
| 1998 |
Mintzer MZ, Frey JM, Griffiths RR. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure. Behavioural Pharmacology. 9: 545-59. PMID 9862080 DOI: 10.1097/00008877-199811000-00010 |
0.771 |
|
| 1998 |
Weerts EM, Griffiths RR. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behavioural Pharmacology. 9: 285-97. PMID 9832941 |
0.564 |
|
| 1998 |
Frey JM, Mintzer MZ, Rush CR, Griffiths RR. Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure. Psychopharmacology. 138: 16-26. PMID 9694522 DOI: 10.1007/S002130050640 |
0.779 |
|
| 1998 |
Weerts EM, Ator NA, Grech DM, Griffiths RR. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. The Journal of Pharmacology and Experimental Therapeutics. 285: 41-53. PMID 9535993 |
0.602 |
|
| 1998 |
Weerts EM, Kaminski BJ, Griffiths RR. Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Psychopharmacology. 135: 70-81. PMID 9489936 DOI: 10.1007/s002130050487 |
0.592 |
|
| 1997 |
Mintzer MZ, Frey JM, Yingling JE, Griffiths RR. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behavioural Pharmacology. 8: 561-74. PMID 9832970 DOI: 10.1097/00008877-199711000-00014 |
0.784 |
|
| 1997 |
Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse. Psychopharmacology. 134: 1-37. PMID 9399364 DOI: 10.1007/s002130050422 |
0.614 |
|
| 1997 |
Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers. Experimental and Clinical Psychopharmacology. 5: 203-15. PMID 9260068 DOI: 10.1037/1064-1297.5.3.203 |
0.772 |
|
| 1997 |
Eissenberg T, Griffiths RR. Human drug discrimination and multiple chemical sensitivity: caffeine exposure as an experimental model. Environmental Health Perspectives. 105: 509-13. PMID 9167988 DOI: 10.1289/Ehp.97105S2509 |
0.476 |
|
| 1996 |
Mumford GK, Benowitz NL, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR. Absorption rate of methylxanthines following capsules, cola and chocolate. European Journal of Clinical Pharmacology. 51: 319-25. PMID 9010706 DOI: 10.1007/S002280050205 |
0.483 |
|
| 1996 |
Eissenberg T, Griffiths RR, Stitzer ML. Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology. 127: 328-36. PMID 8923568 DOI: 10.1007/S002130050094 |
0.462 |
|
| 1996 |
Evans SM, Griffiths RR, de Wit H. Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology. 123: 154-63. PMID 8741938 DOI: 10.1007/BF02246172 |
0.486 |
|
| 1996 |
Mumford GK, Silverman K, Griffiths RR. Reinforcing, subjective, and performance effects of lorazepam and diphenhydramine in humans Experimental and Clinical Psychopharmacology. 4: 421-430. DOI: 10.1037//1064-1297.4.4.421 |
0.501 |
|
| 1995 |
Rush CR, Critchfield TS, Troisi JR, Griffiths RR. Discriminative stimulus effects of diazepam and buspirone in normal volunteers. Journal of the Experimental Analysis of Behavior. 63: 277-94. PMID 7751833 DOI: 10.1901/jeab.1995.63-277 |
0.635 |
|
| 1994 |
Evans SM, Critchfield TS, Griffiths RR. Caffeine reinforcement demonstrated in a majority of moderate caffeine users. Behavioural Pharmacology. 5: 231-238. PMID 11224272 DOI: 10.1097/00008877-199406000-00001 |
0.583 |
|
| 1994 |
Silverman K, Mumford GK, Griffiths RR. A procedure for studying the within-session onset of human drug discrimination. Journal of the Experimental Analysis of Behavior. 61: 181-9. PMID 8169567 DOI: 10.1901/Jeab.1994.61-181 |
0.536 |
|
| 1994 |
Strain EC, Mumford GK, Silverman K, Griffiths RR. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations. Jama. 272: 1043-8. PMID 8089887 DOI: 10.1001/Jama.1994.03520130081037 |
0.541 |
|
| 1994 |
Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR. Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology. 115: 1-8. PMID 7862879 DOI: 10.1007/Bf02244744 |
0.565 |
|
| 1994 |
Silverman K, Mumford GK, Griffiths RR. Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology. 114: 424-32. PMID 7855200 DOI: 10.1007/Bf02249332 |
0.52 |
|
| 1994 |
Silverman K, Kirby KC, Griffiths RR. Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology. 114: 243-7. PMID 7838915 DOI: 10.1007/Bf02244844 |
0.515 |
|
| 1993 |
Troisi 2nd JR, Critchfield TS, Griffiths RR. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice. Behavioural Pharmacology. 4: 217-230. PMID 11224189 |
0.655 |
|
| 1993 |
Griffiths RR, Troisi JR, Silverman K, Mumford GK. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behavioural Pharmacology. 4: 3-13. PMID 11224166 |
0.55 |
|
| 1993 |
Lamb RJ, Griffiths RR. Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons. The Journal of Pharmacology and Experimental Therapeutics. 265: 47-52. PMID 8474029 |
0.458 |
|
| 1993 |
Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug and Alcohol Dependence. 32: 257-66. PMID 8102331 DOI: 10.1016/0376-8716(93)90090-D |
0.675 |
|
| 1992 |
Silverman K, Griffiths RR. Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. Journal of the Experimental Analysis of Behavior. 57: 91-107. PMID 1548451 DOI: 10.1901/Jeab.1992.57-91 |
0.545 |
|
| 1992 |
Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. The New England Journal of Medicine. 327: 1109-14. PMID 1528206 DOI: 10.1056/Nejm199210153271601 |
0.499 |
|
| 1991 |
Evans SM, Critchfield TS, Griffiths RR. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore. British Journal of Addiction. 86: 1625-32. PMID 1686197 DOI: 10.1111/J.1360-0443.1991.Tb01757.X |
0.63 |
|
| 1991 |
de Wit H, Griffiths RR. Testing the abuse liability of anxiolytic and hypnotic drugs in humans Drug and Alcohol Dependence. 28: 83-111. PMID 1679388 DOI: 10.1016/0376-8716(91)90054-3 |
0.492 |
|
| 1991 |
Griffiths RR, Lamb RJ, Sannerud CA, Ator NA, Brady JV. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology. 103: 154-61. PMID 1674158 DOI: 10.1007/Bf02244196 |
0.617 |
|
| 1991 |
Troisi JR, Critchfield T, Griffiths RR. The reinforcing and subjective effects of buspirone and lorazepam Pharmacology Biochemistry and Behavior. 39: 246. DOI: 10.1016/0091-3057(91)90536-B |
0.567 |
|
| 1991 |
Silverman K, Kirby KC, Griffiths RR. Contextual modulation of human stimulant self-administration Pharmacology Biochemistry and Behavior. 39: 245. DOI: 10.1016/0091-3057(91)90529-B |
0.45 |
|
| 1990 |
Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology. 102: 183-90. PMID 2125734 DOI: 10.1007/Bf02245920 |
0.462 |
|
| 1990 |
Silverman K, Griffiths RR. Low-dose caffeine discrimination in normal humans. Nida Research Monograph. 105: 444-5. PMID 1876068 |
0.497 |
|
| 1990 |
Critchfield TS, Griffiths R. Behavioral and subjective effects of buspirone and lorazepam in sedative abusers: supra-therapeutic doses. Nida Research Monograph. 105: 318. PMID 1876027 |
0.615 |
|
| 1990 |
Roache J, Griffiths R. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration Journal of Clinical Psychopharmacology. 10: 137-138. DOI: 10.1097/00004714-199004000-00015 |
0.322 |
|
| 1989 |
Funderburk FR, Griffiths RR, McLeod DR, Bigelow GE, Mackenzie A, Liebson IA, Nemeth-Coslett R. Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users. Drug and Alcohol Dependence. 22: 215-22. PMID 3234245 DOI: 10.1016/0376-8716(88)90021-X |
0.557 |
|
| 1989 |
Griffiths RR, Bigelow GE, Liebson IA. Reinforcing effects of caffeine in coffee and capsules. Journal of the Experimental Analysis of Behavior. 52: 127-40. PMID 2794839 DOI: 10.1901/JEAB.1989.52-127 |
0.504 |
|
| 1989 |
Bickel WK, Higgins ST, Griffiths RR. Repeated diazepam administration: effects on the acquisition and performance of response chains in humans. Journal of the Experimental Analysis of Behavior. 52: 47-56. PMID 2671245 DOI: 10.1901/jeab.1989.52-47 |
0.716 |
|
| 1989 |
Sannerud CA, Brady JV, Griffiths RR. Self-injection in baboons of amphetamines and related designer drugs. Nida Research Monograph. 94: 30-42. PMID 2514366 |
0.483 |
|
| 1987 |
Griffiths RR, Ator NA, Roache JD, Lamb RJ. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacology Series. 3: 83-7. PMID 3823094 DOI: 10.1007/978-3-642-71288-3_10 |
0.481 |
|
| 1987 |
Lamb RJ, Sannerud CA, Griffiths RR. An examination of the intravenous self-administration of phenylpropanolamine using a cocaine substitution procedure in the baboon. Pharmacology, Biochemistry, and Behavior. 28: 389-92. PMID 3685074 DOI: 10.1016/0091-3057(87)90459-X |
0.46 |
|
| 1987 |
Lamb RJ, Griffiths RR. Effects of Ro 15-1788 and CGS 8216 in diazepam-dependent baboons. European Journal of Pharmacology. 143: 205-12. PMID 3121366 DOI: 10.1016/0014-2999(87)90534-6 |
0.489 |
|
| 1987 |
Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR. Nicotine gum: dose-related effects on cigarette smoking and subjective ratings. Psychopharmacology. 92: 424-30. PMID 3114794 DOI: 10.1007/Bf00176472 |
0.606 |
|
| 1987 |
Lamb RJ, Griffiths RR. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology. 91: 268-72. PMID 2882537 DOI: 10.1007/Bf00518175 |
0.464 |
|
| 1987 |
Iguchi M, Griffiths R. Drug self-administration as an indicator of severity potential Pharmacology Biochemistry and Behavior. 27: 601-602. DOI: 10.1016/0091-3057(87)90432-1 |
0.573 |
|
| 1987 |
Bickel WK, Higgins ST, Griffiths RR. The effects of chronic diazepam on repeated acquisition in humans Pharmacology Biochemistry and Behavior. 27: 589-590. DOI: 10.1016/0091-3057(87)90385-6 |
0.669 |
|
| 1986 |
Griffiths RR, Bigelow GE, Liebson IA, O'Keeffe M, O'Leary D, Russ N. Human coffee drinking: manipulation of concentration and caffeine dose. Journal of the Experimental Analysis of Behavior. 45: 133-48. PMID 3958660 DOI: 10.1901/JEAB.1986.45-133 |
0.512 |
|
| 1986 |
Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR. Effects of marijuana smoking on subjective ratings and tobacco smoking. Pharmacology, Biochemistry, and Behavior. 25: 659-65. PMID 3774833 DOI: 10.1016/0091-3057(86)90156-5 |
0.592 |
|
| 1986 |
Griffiths RR, Brady JV, Ator NA, Lamb R, Bigelow GE, Roache JD. Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine. Nida Research Monograph. 67: 93-7. PMID 3092102 |
0.65 |
|
| 1986 |
Nemeth-Coslett R, Henningfield JE, O'Keeffe MK, Griffiths RR. Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology. 88: 420-5. PMID 3085131 DOI: 10.1007/Bf00178502 |
0.612 |
|
| 1985 |
Lamb RJ, Griffiths RR. Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons. European Journal of Pharmacology. 110: 257-61. PMID 2859217 DOI: 10.1016/0014-2999(85)90220-1 |
0.505 |
|
| 1985 |
Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neuroscience and Biobehavioral Reviews. 9: 133-51. PMID 2858078 DOI: 10.1016/0149-7634(85)90039-9 |
0.654 |
|
| 1984 |
Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA. Diazepam and methadone interactions in methadone maintenance. Clinical Pharmacology and Therapeutics. 36: 534-41. PMID 6478738 DOI: 10.1038/Clpt.1984.215 |
0.551 |
|
| 1984 |
Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD. Relative abuse liability of diazepam and oxazepam: Behavioral and subjective dose effects Psychopharmacology. 84: 147-154. PMID 6438672 DOI: 10.1007/Bf00427437 |
0.318 |
|
| 1984 |
Lukas SE, Griffiths RR, Brady JV, Wurster RM. Phencyclidine-analogue self-injection by the baboon. Psychopharmacology. 83: 316-20. PMID 6436860 DOI: 10.1007/Bf00428537 |
0.648 |
|
| 1984 |
Lamb RJ, Griffiths RR. Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896. Drug and Alcohol Dependence. 14: 11-7. PMID 6435982 DOI: 10.1016/0376-8716(84)90013-9 |
0.476 |
|
| 1984 |
Lukas SE, Griffiths RR. Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. European Journal of Pharmacology. 100: 163-71. PMID 6428921 DOI: 10.1016/0014-2999(84)90218-8 |
0.508 |
|
| 1984 |
Henningfield JE, Chait LD, Griffiths RR. Effects of ethanol on cigarette smoking by volunteers without histories of alcoholism. Psychopharmacology. 82: 1-5. PMID 6420817 DOI: 10.1007/Bf00426371 |
0.604 |
|
| 1984 |
Brady JV, Griffiths RR, Hienz RD, Bigelow GE, Emurian HH, Lukas SE, Ator NA, Nellis MJ, Ray RL, Pearlson GD. Abuse liability and behavioral toxicity assessment: progress report from the behavioral biology laboratories of the Johns Hopkins University School of Medicine. Nida Research Monograph. 49: 92-108. PMID 6148698 |
0.761 |
|
| 1984 |
Griffiths RR, Ator NA, Lukas SE, Lamb RJ, Brady JV. Benzodiazepines: drug discrimination and physiological dependence. Nida Research Monograph. 49: 163-4. PMID 6148692 |
0.701 |
|
| 1983 |
Griffiths RR, Bigelow GE, Liebson I. Differential effects of diazepam and pentobarbital on mood and behavior. Archives of General Psychiatry. 40: 865-73. PMID 6870483 DOI: 10.1001/ARCHPSYC.1983.01790070055007 |
0.555 |
|
| 1983 |
Henningfield JE, Chait LD, Griffiths RR. Cigarette smoking and subjective response in alcoholics: effects of pentobarbital. Clinical Pharmacology and Therapeutics. 33: 806-12. PMID 6851412 DOI: 10.1038/Clpt.1983.110 |
0.605 |
|
| 1983 |
Brady JV, Griffiths RR. Testing drugs for abuse liability and behavioral toxicity: progress report from the laboratories at the Johns Hopkins University School of Medicine. Nida Research Monograph. 43: 99-124. PMID 6135997 |
0.487 |
|
| 1982 |
Lukas SE, Griffiths RR, Bradford LD, Brady JV, Daley L. A tethering system for intravenous and intragastric drug administration in the baboon. Pharmacology, Biochemistry, and Behavior. 17: 823-9. PMID 7178190 DOI: 10.1016/0091-3057(82)90366-5 |
0.614 |
|
| 1982 |
Griffiths RR, Bradford LD, Lukas SE, Brady JV, Snell JD. Comparison of barbiturate and benzodiazepine self-injection in the baboon. Nida Research Monograph. 41: 190. PMID 6811908 |
0.593 |
|
| 1982 |
Lukas SE, Griffiths RR. Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science (New York, N.Y.). 217: 1161-3. PMID 6287579 DOI: 10.1126/Science.6287579 |
0.446 |
|
| 1982 |
McLeod DR, Griffiths RR, Bigelow GE, Yingling J. An automated version of the digit symbol substitution test (DSST) Behavior Research Methods &Amp; Instrumentation. 14: 463-466. DOI: 10.3758/BF03203313 |
0.435 |
|
| 1982 |
Griffiths RR, Henningfield JE. Pharmacology of cigarette smoking behavior Trends in Pharmacological Sciences. 3: 260-263. DOI: 10.1016/0165-6147(82)91122-1 |
0.555 |
|
| 1981 |
Bigelow GE, Stitzer ML, Griffiths RR, Liebson IA. Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations. Addictive Behaviors. 6: 241-52. PMID 7293847 DOI: 10.1016/0306-4603(81)90022-8 |
0.468 |
|
| 1981 |
Henningfield JE, Griffiths RR. Cigarette smoking and subjective response: effects of d-amphetamine. Clinical Pharmacology and Therapeutics. 30: 497-505. PMID 7285484 DOI: 10.1038/Clpt.1981.194 |
0.598 |
|
| 1981 |
Griffiths RR, Wurster RM, Brady JV. Choice between food and heroin: effects of morphine, naloxone, and secobarbital. Journal of the Experimental Analysis of Behavior. 35: 335-51. PMID 7241034 DOI: 10.1901/jeab.1981.35-335 |
0.523 |
|
| 1981 |
Stitzer ML, Griffiths RR, Bigelow GE, Liebson I. Human social conversation: effects of ethanol, secobarbital and chlorpromazine. Pharmacology, Biochemistry, and Behavior. 14: 353-60. PMID 7232461 DOI: 10.1016/0091-3057(81)90402-0 |
0.518 |
|
| 1981 |
Henningfield JE, Ator NA, Griffiths RR. Establishment and maintenance of oral ethanol self-administration in the baboon. Drug and Alcohol Dependence. 7: 113-24. PMID 7195797 DOI: 10.1016/0376-8716(81)90025-9 |
0.561 |
|
| 1981 |
Henningfield JE, Griffiths RR. Effects of ventilated cigarette holders on cigarette smoking by humans. Psychopharmacology. 68: 115-9. PMID 6776555 DOI: 10.1007/Bf00432127 |
0.572 |
|
| 1981 |
Griffiths RR, Lukas SE, Bradford LD, Brady JV, Snell JD. Self-injection of barbiturates and benzodiazepines in baboons. Psychopharmacology. 75: 101-9. PMID 6119723 DOI: 10.1007/Bf00432169 |
0.647 |
|
| 1980 |
Henningfield JE, Stitzer ML, Griffiths RR. Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked. Addictive Behaviors. 5: 265-72. PMID 7435315 DOI: 10.1016/0306-4603(80)90049-0 |
0.567 |
|
| 1980 |
Henningfield JE, Yingling J, Griffiths RR, Pickens R. An inexpensive portable device for measuring puffing behavior by cigarette smokers Pharmacology, Biochemistry and Behavior. 12: 811-813. PMID 7393977 DOI: 10.1016/0091-3057(80)90171-9 |
0.543 |
|
| 1980 |
Bigelow GE, Griffiths RR, Liebson I, Kaliszak JE. Double-blind evaluation of reinforcing and anorectic actions of weight control medications. Interaction of pharmacological and behavioral treatments. Archives of General Psychiatry. 37: 1118-23. PMID 7000029 DOI: 10.1001/ARCHPSYC.1980.01780230036005 |
0.494 |
|
| 1979 |
Griffiths RR, Bradford LD, Brady JV. Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons. Psychopharmacology. 65: 125-36. PMID 117480 DOI: 10.1007/BF00433038 |
0.522 |
|
| 1979 |
Henningfield JE, Griffiths RR. A preparation for the experimental analysis of human cigarette smoking behavior Behavior Research Methods & Instrumentation. 11: 538-544. DOI: 10.3758/Bf03201375 |
0.565 |
|
| 1978 |
Griffiths RR, Stitzer M, Corker K, Bigelow G, Liebson I. Drug-produced changes in human social behavior: facilitation by d-amphetamine. Pharmacology, Biochemistry, and Behavior. 7: 365-72. PMID 928495 DOI: 10.1016/0091-3057(77)90233-7 |
0.496 |
|
| 1978 |
Bigelow GE, Griffiths RR, Liebson IA. Pharmacological influences upon human ethanol self-administration. Advances in Experimental Medicine and Biology. 523-38. PMID 596286 DOI: 10.1007/978-1-4615-9038-5_33 |
0.42 |
|
| 1978 |
Griffiths RR, Brady JV, Snell JD. Progressive-ratio performance maintained by drug infusions: comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine. Psychopharmacology. 56: 5-13. PMID 415327 DOI: 10.1007/BF00571401 |
0.546 |
|
| 1977 |
Bigelow GE, Griffiths RR, Liebson IA. Effects of response requirement upon human sedative self-administration and drug-seeking behavior. Pharmacology, Biochemistry, and Behavior. 5: 681-5. PMID 1023234 DOI: 10.1016/0091-3057(76)90311-7 |
0.522 |
|
| 1977 |
Wurster RM, Griffiths RR, Findley JD, Brady JV. Reduction of heroin self-administration in baboons by manipulation of behavioral and pharmacological conditions. Pharmacology, Biochemistry, and Behavior. 7: 519-28. PMID 413116 DOI: 10.1016/0091-3057(77)90248-9 |
0.521 |
|
| 1976 |
Griffiths RR, Bigelow GE, Liebson I. Facilitation of human tobacco self-administration by ethanol: a behavioral analysis. Journal of the Experimental Analysis of Behavior. 25: 279-92. PMID 1270971 DOI: 10.1901/JEAB.1976.25-279 |
0.452 |
|
| 1976 |
Griffiths RR, Winger G, Brady JV, Snell JD. Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology. 50: 251-8. PMID 826970 DOI: 10.1007/BF00426841 |
0.535 |
|
| 1975 |
Griffiths R, Bigelow G, Liebson I. Assessment of effects of ethanol self-administration on social interactions in alcoholics. Psychopharmacologia. 38: 105-10. PMID 4460068 DOI: 10.1007/BF00426105 |
0.424 |
|
| 1975 |
Griffiths RR, Findley JD, Brady JV, Dolan-Gutcher K, Robinson WW. Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital. Psychopharmacologia. 43: 81-3. PMID 1161995 DOI: 10.1007/BF00437619 |
0.543 |
|
| 1975 |
Griffiths R, Bigelow G, Liebson I. Effect of ethanol self-administration on choice behavior: money vs. socializing. Pharmacology, Biochemistry, and Behavior. 3: 443-6. PMID 1153447 DOI: 10.1016/0091-3057(75)90054-4 |
0.459 |
|
| 1974 |
Griffiths RR, Thompson T. Pentobarbital facilitated extinction: effects of different schedules of drug withdrawal. Pharmacology, Biochemistry, and Behavior. 2: 331-8. PMID 4858098 DOI: 10.1016/0091-3057(74)90077-X |
0.702 |
|
| 1973 |
Griffiths RR, Thompson T. Effects of chlorpromazine and pentobarbital on pattern and number of responses in extinction. Psychological Reports. 33: 323-34. PMID 4728477 DOI: 10.2466/pr0.1973.33.1.323 |
0.7 |
|
| 1973 |
Pickens R, Bigelow G, Griffiths R. An experimental approach to treating chronic alcoholism: a case study and one-year follow-up. Behaviour Research and Therapy. 11: 321-5. PMID 4125499 DOI: 10.1016/0005-7967(73)90010-7 |
0.409 |
|
| 1973 |
Griffiths RR, Thompson T. The Post-Reinforcement Pause: A Misnomer The Psychological Record. 23: 229-235. DOI: 10.1007/BF03394160 |
0.643 |
|
| Show low-probability matches. |